Showing results (851-860 of 2,290) with videos related to
Sort By:
Pageof 229
Studies in Health Technology and Informatics|October 1, 2004
4-dimensional computer-based motion simulation after Total Hip ArthroplastyYoshito Otake, Keisuke Hagio, Naoki Suzuki, et al.International Journal of Molecular Sciences|July 26, 2018
Involvement of Endocytosis in the Transdermal Penetration Mechanism of Ketoprofen NanoparticlesNoriaki Nagai, Fumihiko Ogata, Miyu Ishii, et al.The Journal of Veterinary Medical Science|September 6, 2016
Temporal deterioration of neurological symptoms and increase of serum acetylcholine receptor antibody levels after thymectomy: a case report of a cat with myasthenia gravisNao Nagata, Takuma Miyoshi, Yuzo Otake, et al.Journal of Orthopaedic Surgery (Hong Kong)|June 2, 2018
The distribution of bone mineral density in the femoral heads of unstable intertrochanteric fracturesKeisuke Uemura, Masaki Takao, Yoshito Otake, et al.Journal of Agricultural and Food Chemistry|August 26, 2009
Development of certified reference material for quantification of two pesticides in brown riceTakamitsu Otake, Nobuyasu Itoh, Yoshie Aoyagi, et al.Life Sciences|November 13, 2010
AMP-activated protein kinase regulates the expression of monocarboxylate transporter 4 in skeletal muscleAyako Furugen, Masaki Kobayashi, Katsuya Narumi, et al.Clinical & Experimental Neuroimmunology|November 8, 2016
Current treatment status and medical cost for multiple sclerosis based on analysis of a Japanese claims databaseMieko Ogino, Izumi Kawachi, Kazuyoshi Otake, et al.Odontology|December 26, 2015
The interactions between different tastes on initiation of reflex swallow elicited by electrical stimulation in humansMasanori Otake, Masayuki Kurose, Yoshiaki Uchida, et al.Disease Markers|January 14, 2020
Beta-3-adrenergic Receptor rs4994 Polymorphism Is a Potential Biomarker for the Development of Nonalcoholic Fatty Liver Disease in Overweight/Obese IndividualsYuki Sakamoto, Kentaro Oniki, Naoki Kumagae, et al.The Journal of Antibiotics|November 27, 2021
TP0586532, a non-hydroxamate LpxC inhibitor, has in vitro and in vivo antibacterial activities against EnterobacteriaceaeKiyoko Fujita, Iichiro Takata, Ippei Yoshida, et al.Pageof 229